Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Becton Dickinson

This article was originally published in The Gray Sheet

Executive Summary

Files suit against Unilever, American Home Products and Carter- Wallace for infringement of patents covering the testing process used in B-D's Precise hCG home pregnancy test. B-D alleges that Unilever's Clearblue Easy pregnancy test, Clearplan Easy ovulation test and Clearview rapid tests for pregnancy, group A streptococcus and chlamydia violate the patents. American Home distributes Clearblue and Clearplan products in the U.S.; Carter- Wallace markets the Clearview line. B-D says it filed the suit after trying for more than a year to negotiate a royalty/licensing agreement with the firms. The company has successfully negotiated "several" such pacts with other firms using the testing process, according to a spokesperson.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT000804

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel